GlaxoSmithKline
Last updated on 2013-11-22T06:52+0300.
About this
image
License:
UNKNOWN
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|---|---|---|
| british rival | 50.00% | EN | 02/02/2007 |
| candidate | 50.00% | EN | 15/11/2005 |
| Names | Lang | Count |
|---|---|---|
| GlaxoSmithKline | EN | 22.94% |
| GlaxoSmithKline | FR | 8.56% |
| GlaxoSmithKline | PT | 5.87% |
| GlaxoSmithKline | ES | 5.26% |
| GlaxoSmithKline | DE | 5.20% |
| GlaxoSmithKline | AF | 5.20% |
| GlaxoSmithKline | PL | 5.20% |
| GlaxoSmithKline | TR | 5.20% |
| GlaxoSmithKline | NN | 5.20% |
| GlaxoSmithKline | RU | 5.20% |
| GlaxoSmithKline | NO | 5.20% |
| GlaxoSmithKline | UK | 5.20% |
| GlaxoSmithKline | HR | 5.20% |
| GlaxoSmithKline | AR | 5.20% |
| Glaxo Smith Kline | EN | 0.98% |
| GLAXOSMITHKLINE | EN | 0.90% |
| Glaxo Smith Kline | FR | 0.90% |
| Glaxo Smith Kline | SV | 0.84% |
| Glaxo-Smith-Kline | DE | 0.53% |
| GlaxoSmithKline | SA | 0.39% |
| Glaxo Smithkline | ES | 0.29% |
| Glaxo Smithkline | EN | 0.29% |
| Glaxo Smith Klein | EN | 0.12% |
| Glaxo SmithKline | EN | 0.10% |
| GLAXOSMITHKLINE | FR | 0.06% |
| Glaxo Smithkline | FR | 0.02% |
| GLAXOSMITHKLINE | SA | 0.02% |
| Pharmakonzern Glaxo Smithkline | DE | 0.00% |
| 葛蘭素史克 | ZH | 0.00% |
| Pharmariesen Glaxo Smith Kline | DE | 0.00% |
| Type | Entity Name | Count |
|---|---|---|
 | Pfizer Inc | 5.01% |
 | British | 3.61% |
| Inc | 2.61% |
| University College | 1.80% |
| Commission | 1.70% |
| Reuters Group | 1.50% |
| Oxford University | 1.40% |
| European Commission | 1.20% |
| World Health Organization | 1.20% |
| Cambridge University | 1.10% |
| Vincent Enouf | 1.10% |
| Institut Pasteur | 1.10% |
| European Union | 1.10% |
| Ravi Gupta | 1.10% |
| Joseph Biden | 1.10% |
| Drug Administration | 0.90% |
| College London | 0.90% |
| S government | 0.80% |
| Wall Street | 0.70% |
| GlaxoSmithKline Plc | 0.70% |
| Laurent Cipriani | 0.70% |
| The UK | 0.70% |
| Boris Johnson | 0.70% |
| Donald Trump | 0.60% |
| Centers for Disease Control and Prevention | 0.60% |
| Moncef Slaoui | 0.60% |
| New England Journal of Medicine | 0.60% |
| United Nations | 0.60% |
| National Health | 0.60% |
| Copyright | 0.50% |
| Type | Entity Name | Score |
|---|---|---|
| University College | 0.0158 |
| Ravi Gupta | 0.011 |
| Institut Pasteur | 0.0107 |
| Vincent Enouf | 0.0101 |
| Jonathan Ledermann | 0.0093 |
| Pfizer Inc | 0.0092 |
| Cambridge University | 0.0091 |
| Oxford University | 0.0073 |
| Laurent Cipriani | 0.0073 |
| GlaxoSmithKline Plc | 0.007 |
| Drug Administration | 0.0067 |
| College London | 0.0062 |
| New England Journal of Medicine | 0.0057 |
| Moncef Slaoui | 0.0054 |
| Dan Suzuki | 0.005 |
| Fujifilm | 0.0049 |
| Inc | 0.0048 |
| Bloomberg LP | 0.0046 |
| British | 0.0045 |
| Douglas Cole | 0.0044 |
| National Health | 0.0041 |
| Just Eat | 0.0041 |
| Bespoke Investment Group | 0.0041 |
| S government | 0.004 |
| Novartis | 0.004 |
| Bristol Myers Squibb | 0.004 |
| Jeffrey Halley | 0.0039 |
| Suzuki Motors | 0.0039 |
| Richard Bernstein | 0.0038 |
| Sanofi Aventis | 0.0038 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Wednesday, January 20, 2021
4:43:00 PM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 